Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Biomarkers

Drew M. Pardoll

M.D., Ph.D.

🏢Johns Hopkins University🌐USA

Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy

2
Key Papers
2
Key Contributions

👥Biography 个人简介

Drew Pardoll is a pioneer in cancer immunology who has made foundational contributions to understanding the PD-1/PD-L1 pathway and its role in tumor immune evasion. His laboratory discovered that PD-L1 expression by tumor cells directly inhibits T cell function, providing the mechanistic basis for PD-1/PD-L1 blockade therapy. Pardoll continues to lead efforts to understand and overcome immunotherapy resistance.

Drew Pardoll是癌症免疫学的先驱,在理解PD-1/PD-L1通路及其在肿瘤免疫逃逸中的作用方面做出了基础性贡献。他的实验室发现肿瘤细胞表达的PD-L1直接抑制T细胞功能,为PD-1/PD-L1阻断治疗提供了机制基础。Pardoll继续领导理解和克服免疫治疗耐药的努力。

Share:

🧪Research Fields 研究领域

Cancer Immunology癌症免疫学
PD-1/PD-L1 PathwayPD-1/PD-L1通路
Tumor Microenvironment肿瘤微环境

🎓Key Contributions 主要贡献

PD-L1 Discovery

Demonstrated that tumor PD-L1 expression mediates immune evasion through PD-1 engagement.

Combination Immunotherapy

Developed rationale for combining checkpoint inhibitors with other modalities.

Representative Works 代表性著作

[1]

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Nature Medicine (1999)

Original characterization of PD-L1 (B7-H1).

[2]

The blockade of immune checkpoints in cancer immunotherapy

Nature Reviews Cancer (2012)

Comprehensive review establishing checkpoint blockade paradigm.

📄Data Sources 数据来源

Last updated: 2026-03-04 | All information from publicly available academic sources

关注 Drew M. Pardoll 的研究动态

Follow Drew M. Pardoll's research updates

留下邮箱,当我们发布与 Drew M. Pardoll(Johns Hopkins University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment